| Tag | Content |
|---|
EnhancerAtlas ID | HS139-15628 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr13:100199360-100201410 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOXP2 | MA0593.1 | chr13:100199821-100199832 | AAGTAAACAAA | + | 6.62 | | Gfi1b | MA0483.1 | chr13:100200714-100200725 | AAATCACAGCT | + | 6.14 | | KLF4 | MA0039.3 | chr13:100200447-100200458 | CCACACCCTGC | + | 6.62 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_59008 | chr13:100180436-100203137 | Ly3 | | SE_61126 | chr13:100180005-100203876 | HBL1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr13 | 100200600 | 100201000 | | chr13 | 100200890 | 100201070 |
|
Enhancer Sequence | AAGTCAAAGC CACTGTGACT GGCGTCTGAT CAGGAAGGGA CTCTGCTGCG GCTGTGGATC 60
TGACCTGGGT ATCAGATGGT GATGCTTTGT AAATAGTGTG CCTCATAGGG GTCTGTTCTT 120
AGTTAAAAGG AGCCTGCTTG GTGATTCCTT TTGTGTCATG AGTTACTATC CCAAAATTTA 180
TTTGTTCGAA AATGTTTAGT GAAACAAGCA AATTGTGCCA CTTATCCACT ATCCCCTCCC 240
TCTTTTTTTC TTTAAGCTTT GGCTAACAGG TTGGGCTGAA CAGCTTAGAT TTGCTGTGTT 300
CATAGAAGCA CATATAGACT AATAAAGGAG AAAAGTATAC AAATGAGTAT CACTGATTTT 360
TTTCACTAAA ACAACTAGTA CATCTAGGTG TACCTTTTCT TACATATGAG AAGTCATACT 420
TACATTGTAT CAATTTAATA TTTATAAAAA TACACTGTTT CAAGTAAACA AAGATCTCAT 480
TATTTTGGAG ACCTGGAAAG TTACTTTTGT AATATCATTA GTCACAATCT CTTGTGTTCT 540
TGCATTCTAG AAGTAAAATA AAGTTCAGTG AAACAAAAGG CTCACGGCCA CAGAGTAAGG 600
CTGAGATGGG ACTGGATGGC TTAGAAAGCA GCTGGCAGGG TCAGCAGGGA CCAGAGCTGG 660
CCTCCTCGGG AATGCCACAG TCTCGTCTGG GATATACAGT GATTCCCCAC GGTCTAGCAA 720
TGTGAAAAAG TTTTGAGGTG AAGCACAGTA GAGTTACGTG GACAACCTTA ATGTGGGGTT 780
GGGTAGTCTC AGCCCCCAGT AAAAGATTAA CTTAGACCTT GTCAGACACA GTTCTCTCTT 840
GAGTATGTGA AGCCCTGTAT GTATGTGTGT TTTAAGTGTG TTTTAATTTC TGTGAATTTT 900
GTCAAGTTCT TTCTTCCCCT TTACTAAAGG AGGTAGGATT AGGGCCATCA TACGGATTTT 960
AATGCATACA AAATACAGTC AGCCCTTTGC CTGCCACACC AGCCTTACTT CATGCCACAC 1020
TCCCCCTTTC TCACCATTTC AGCCACACAG GCTTTCTGTC GGTTCCTCGG ACAGGCTGCC 1080
TGCTTTCCCA CACCCTGCTC CCATCTGCAC TCCACTCACT AATGCCTCCC CATCCTTCAG 1140
GTCTCCCAGC TGCAGATCCT GTATTACTTG AATTTTGACT GAAATTATAG TAAACCCAGA 1200
ATTAATCATT TCATAACAGT CTGTTTATCA GAAACATTGT GAGTTCAAAT CATGATACAT 1260
ATATATGATC TTATGTGTAT ATGTAATTTT ATTATTTTCT TTTAGGGCAA GTGGCACTTA 1320
AACTTGCCTA TCAACTATGT TAAAACTTTT TTAAAAATCA CAGCTGTTCT GAGATCTCAG 1380
CCAGTTTCAT TTCTGACTTA AACTGGGAGC AGACGTGTAC TTTCATTTTT CACTCTAGCT 1440
ACTTCAGTAT TTGAATTCTT TAAACTGGAA AAAAAAGCAA GTTGGAGAGG GGCAAAGGAG 1500
AGTAAAACAT ATATTAGCAA ACATGGTCTG TCAAATGGTC ATAACCCTTC TACTCTTCTT 1560
AGTTGCCTCA TCTGACACAC GCACCTCCTA GGAACCACAG TTCCTCCTAG AAACCACAGT 1620
GCTAGAGGAA GAGTTGGCCT ACTGTGGAAG TGTAAATGTG TTGCACATCA GGCTTGACGG 1680
TTCCCAGTTT TATAACAAAT TCTGAAACTG ACTGCAAGAT AAGTGAGAAT CCCGTGTGCC 1740
CTTCCTGTGC CTAGGCCCAT TGATTGATAC TGGCTCAGGA TTTAAGGATT CTTTTGGTTG 1800
TGAGGGGAAA AGAAGAACTG ATCTTGATGA CTTGCCTCTG ATTCTCTAGA GCAGGACTTA 1860
CCTAGGGAAT CCCATCCTGT ATGTCTCAGA TTTGGATTAT TTAATAAAGG AATATCATAT 1920
TATATTTGCT AGTACCATTT TCTAGGAATG AGTACTCATT GCTGTCTGAC AGTTTGGCAA 1980
ATATCAGACT TGTAATATGG ATATTTGGTT TGCTTTAAAG AAAATCTGTA TTTATACAAC 2040
TTTTGTTTTC 2050
|
